Our company goal is preventing blindness for the estimated 80 million people who will suffer from glaucoma by 2020.
Our product, under development, addresses an unmet need by rendering accessible a continuous measurement of the intraocular pressure.
The key benefits for the medical professional and the patient is to increase the quality and relevance of diagnostic and treatment of glaucoma.
Tissot Medical Research is proud to annouce that company has obtained certification to ISO13485:2016. Certificate is released and available.
June 2018 - 2021 : Participation to exhibition “Excellence and education”, Le Locle, Ancienne Poste. www.salle407.ch
Together they are 230 years old. And have just launched their third start-up. Luc Tissot and his two colleagues have developed special contact lenses that measure the internal pressure of the eye fluid. The know-how from precision mechanics is no...
EPFL researchers have participated in the development of a contact lens for the early detection of glaucoma. Clinical trials are being conducted at the CHUV. Glaucoma, which results from excessive pressure in the eye, is the second leading cause of...
Luc Tissot, heir to the illustrious watchmaking family, has been diversifying for forty years and the activities of his small local company. His last success: a revolutionary lens that detect glaucoma. Article Largeur 2012-09-03 (in french)
It is the second leading cause of blindness in the world, behind cataracts: by 2020, glaucoma is expected to affect 80 million people. But this disease, which damages the optic nerve, is not always obvious to diagnose at the early stage. Founded at the end...